STEMI Clinical Trials in Perth, Western Australia
4 recruitingPerth, Western Australia, Australia
Showing 1–4 of 4 trials
Recruiting
Phase 3
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Lymphoma, T-CellPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell Lymphoma+4 more
Corvus Pharmaceuticals, Inc.150 enrolled34 locationsNCT06561048
Recruiting
Phase 2
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Systemic Lupus ErythematosusActive Refractory Rheumatoid Arthritis
Amgen220 enrolled52 locationsNCT06570798
Recruiting
Phase 3
A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.
STEMIElevated IMR (>32)
University of Sydney445 enrolled22 locationsNCT03998319
Recruiting
Phase 1
Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis
Amyloidosis; Systemic
Attralus, Inc.100 enrolled11 locationsNCT05521022